An explorative cost-effectiveness analysis of school-based screening for child anxiety using a decision analytic model

European Child and Adolescent Psychiatry

Volumn 22, Issue 10, 2013, Pages 619-630

  Simon, Ellin ^a   Dirksen, Carmen D ^a   Bögels, Susan M ^a  

^a NONE

Author keywords

Anxiety; Cost effectiveness; Decision analytic model; Intervention, Screening; Prevention

Indexed keywords

ANXIETY DISORDER; ARTICLE; CHILD; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DECISION ANALYTIC MODEL; DEMOGRAPHY; EARLY INTERVENTION; EDUCATION; ETHNICITY; FEMALE; FOLLOW UP; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; MENTAL HEALTH CARE; PARENTAL AGE; SCHOOL CHILD; SCHOOL HEALTH SERVICE; SCREENING TEST; SOCIOECONOMICS;

ANXIETY; CHILD; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MASS SCREENING; PARENTS; RESEARCH DESIGN; SCHOOLS; TREATMENT OUTCOME;

EID: 84885602941     PISSN: 10188827     EISSN: 1435165X     Source Type: Journal    
DOI: 10.1007/s00787-013-0404-z     Document Type: Article

References (32)

1. Costello EJ, Egger H, Angold A (2005) The developmental epidemiology of anxiety disorders: phenomenology, prevalence, and comorbidity. Child Adolesc Psychiatr Clin N Am 14:631-648
2. Kessler RC, Berglund P, Demler O et al (2005) Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62:593-602
3. Bodden DHM, Dirksen CD, Bögels SM (2008) Societal burden of clinically anxious youth referred for treatment: a cost-of-illness study. J Abnorm Child Psychol 36(4):487-497
4. Hudson JL, Kendall PC, Coles ME et al (2002) The other side of the coin: using intervention research in child anxiety disorders to inform developmental psychopathology. Dev Psychopathol 14:819-841
5. Cohen P, Cohen J, Kasen S et al (1993) An epidemiological study of disorders in late childhood and adolescence-I: age- and gender-specific prevalence. Eur Child Adolesc Psychiatry 34:851-867
6. Feehan M, McGee R, Williams SM (1993) Mental health disorders from age 15 to age 18 years. J Am Acad Child Adolesc Psychiatry 32:1118-1126
7. Keller M, Lavori P, Wunder J et al (1992) Chronic course of anxiety disorders in children and adolescents. J Am Acad Child Adolesc Psychiatry 31:595-599
8. Christiana JM, Gilman SE, Guardino M et al (2000) Duration between onset and time of obtaining initial treatment among people with anxiety and mood disorders: an international survey of members of mental health patient advocate groups. Psychol Med 30:693-703
9. Mifsud C, Rapee RM (2005) Early intervention for childhood anxiety in a school setting: outcomes for an economically disadvantaged population. J Am Acad Child Adolesc Psychiatry 44:996-1004
10. Dadds MR, Spence SH, Holland DE et al (1997) Prevention and early intervention for anxiety disorders. J Consult Clin Psychol 65:627-635
11. Mzarek PJ, Haggerty RJ (1994) Reducing risks for mental disorders: frontiers for preventive intervention research. National Academic Press, Washington
12. Rapee RM, Kennedy S, Ingram M et al (2005) Prevention and early intervention of anxiety disorders in inhibited preschool children. J Consult Clin Psychol 73(3):488-497
13. In-Albon T, Schneider S (2007) Psychotherapy of childhood anxiety disorders. Psychother Psychosom 76:15-24
14. Simon E, Bögels SM, Voncken MJ (2011) Efficacy of child-focused and parent-focused interventions in a child anxiety prevention study. J Clin Child Adolesc Psychol 40:204-219
15. Simon E, Dirksen CD, Bögels SM, Bodden DHM (2011) Cost-effectiveness of child-focused and parent-focused interventions in a child anxiety prevention program. J Anxiety Disord 26:287-296
16. Bodden DHM, Bögels SM, Muris P (2009) The diagnostic utility of the Screen for Child Anxiety Related Emotional Disorders-71 (SCARED-71). Behav Res Ther 47(5):418-425
17. Freer CB (1980) Health diaries: a method of collecting health information. J R Coll Gen Pract 30:279-282
18. Goossens MEJB, Rutten-Van Mölken MPMH, Vlaeyen JWS, Van der Linden SMJP (2000) The cost diary: a method to measure direct and indirect costs in cost-effectiveness research. J Clin Epidemiol 53:688-695
19. Oostenbrink JB, Koopmanschap MA, Rutten FFH (2004) Handleiding voor kostenonderzoek: Methoden en richtlijnprijzen voor economische evaluaties in de gezondheidszorg. College voor zorgverzekeringen, Amstelveen
20. Siebelink BM, Treffers PDA (2001) Nederlandse bewerking van het Anxiety Disorder Interview Schedule for DSM-IV: Child version van W. K. Silverman en A.M Albana. Swets & Zeitlinger, Lisse/Amsterdam
21. Silverman WK, Albano AM (1996) Anxiety disorders interview schedule for DSM-IV child version, child interview schedule. Psychological Corporation, San Antonio
22. Silverman WK, Saavedra LM, Pina AA (2001) Test-retest reliability of anxiety symptoms and diagnoses with anxiety disorders interview schedule for DSM-IV: child and parent versions. J Am Acad Child Adolesc Psychiatry 40:937-944
23. Bodden DHM, Bögels SM, Muris P (2009) The diagnostic utility of the Screen for Child Anxiety Related Emotional Disorders-71 (SCARED-71). Behav Res Ther 47:418-425
24. Simon E, Bögels SM (2009) Screening for anxiety disorders in children. Eur J Child Adolesc Psychiatry 18:625-634
25. Hirschfeld-Becker DR, Biederman J, Faraone SV, Robin JA et al (2004) Pregnancy complications associated with childhood anxiety disorders. Depress Anxiety 19:152-162
26. Cohen J (1977) Statistical power analysis for the behavioral sciences. Academic Press, New York
27. Bögels SM, Van Melick M (2004) The relationship between child-report, parent self-report and partner report of perceived parental rearing behaviors and anxiety in children and parents. Personality Individ Differ 37:1583-1596
28. Bodden DHM, Dirksen CD, Bögels SM et al (2008) Cost- and cost-effectiveness of family CBT versus individual CBT in clinically anxious children. Clin Child Psychol Psychiatry 13:543-564
29. O'Brien BJ, Drummond MF (1994) Statistical versus quantitative significance in the socioeconomic evaluation of medicines. PharmacoEconomics 5:389-398
30. Claxton K, Sculpher M, McCabe C et al (2005) Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra. Health Econ 14:339-347
31. Brazier J, Roberts J, Tsuchiya A, Busschbach JJF (2004) A comparison of the EQ-5D and the SF-6D across seven patient groups. Health Econ 13:873-884
32. Bharmal M, Thomas J 3rd (2006) Comparing the EQ-5D and the SF-6D descriptive systems to assess their ceiling effects in the US general population. Value Health 9:262-271